AAAAAA

   
Results: 1-10 |
Results: 10
Drug-resistant human laryngeal carcinoma cells have increased levels of cathepsin B
Authors: Osmak, M Svetic, B Gabrijecic-Geiger, D Skrk, J
Citation: M. Osmak et al., Drug-resistant human laryngeal carcinoma cells have increased levels of cathepsin B, ANTICANC R, 21(1A), 2001, pp. 481-483
Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia
Authors: Brozovic, A Simaga, S Osmak, M
Citation: A. Brozovic et al., Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia, NEOPLASMA, 48(2), 2001, pp. 99-103
Cytotoxic effect of four root filling materials
Authors: Miletic, I Anic, I Karlovic, Z Marsan, T Pezelj-Ribaric, S Osmak, M
Citation: I. Miletic et al., Cytotoxic effect of four root filling materials, ENDOD DENT, 16(6), 2000, pp. 287-290
The mutagenic potential of AH+ and AH26 by Salmonella/microsome assay
Authors: Jukic, S Miletic, I Anic, I Britvic, S Osmak, M Sistig, S
Citation: S. Jukic et al., The mutagenic potential of AH+ and AH26 by Salmonella/microsome assay, J ENDODONT, 26(6), 2000, pp. 321-324
Diazenes as modificators of drug-resistance in tumor cells
Authors: Osmak, M Bordukalo, T Ristov, AA Jernej, B Kosmrlj, J Polanc, S
Citation: M. Osmak et al., Diazenes as modificators of drug-resistance in tumor cells, NEOPLASMA, 47(6), 2000, pp. 390-395
Diazene JK-279: potential anticancer drug
Authors: Osmak, M Bordukalo, T Jernej, B Kosmrlj, J Polanc, S
Citation: M. Osmak et al., Diazene JK-279: potential anticancer drug, ANTI-CANC D, 10(9), 1999, pp. 853-859
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis
Authors: Osmak, M Niksic, D Brozovic, A Ristov, AA Vrhovec, I Skrk, J
Citation: M. Osmak et al., Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis, ANTICANC R, 19(4B), 1999, pp. 3193-3197
Cisplatin resistant glioblastoma cells may have increased concentration ofurokinase plasminogen activator and plasminogen activator inhibitor type 1
Authors: Osmak, M Vrhovec, I Skrk, J
Citation: M. Osmak et al., Cisplatin resistant glioblastoma cells may have increased concentration ofurokinase plasminogen activator and plasminogen activator inhibitor type 1, J NEURO-ONC, 42(2), 1999, pp. 95-102
Reversal of carboplatin resistance in human laryngeal carcinoma cells
Authors: Vukovic, L Osmak, M
Citation: L. Vukovic et M. Osmak, Reversal of carboplatin resistance in human laryngeal carcinoma cells, NEOPLASMA, 46(6), 1999, pp. 335-341
Diazenes: modificators of tumor cell resistance to cisplatin
Authors: Osmak, M Bordukalo, T Kosmrlj, J Kvajo, M Marijanovic, Z Eljuga, D Polanc, S
Citation: M. Osmak et al., Diazenes: modificators of tumor cell resistance to cisplatin, NEOPLASMA, 46(4), 1999, pp. 201-206
Risultati: 1-10 |